openPR Logo
Press release

EU Publishes Draft Guidance and Seeks Comments on PAH Restrictions under REACH

02-24-2017 06:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: SGS

/ PR Agency: Sugarloaf Marketing
EU Publishes Draft Guidance and Seeks Comments on PAH

The European Chemicals Agency (ECHA) is seeking comments on a draft guidance document, published in January 2017, on the restriction of polycyclic aromatic hydrocarbons (PAHs) in plastic and rubber materials. The draft guidelines assist stakeholders in complying with restrictions enforced under entry 50 in Annex XVII of REACH.

The guidelines relate to an expansion in the scope of PAH restrictions introduced, via Regulation (EU) 1272/2013, in December 2013. The amendment became effective in December 2015 and saw an enlargement in the extent of the restrictions, which now go beyond covering just tires to include plastic and rubber materials used in:

• Toys
• Childcare articles
• Articles for the general public, for example:
o Clothing, footwear, gloves and sportswear
o Household utensils, trolleys and walking frames
o Sports equipment
o Tools for domestic use
o Watch-straps, wrist-bands, masks, head-bands and other similar articles
o Miscellaneous articles, including:
- Erasers
- Carpet piles in artificial grass
- Holding areas in writing instruments
- Manicure/pedicure tools such as nail files
- Outer casings in cigarette lighters
- Pocket articles such as cosmetic or powder containers
- Tiles and mats used in playgrounds and sports fields
- Grips, upholstery of seats, seat belts, gear sticks and steering wheels in vehicles such as cars, scooters and boats

The restrictions apply if the materials, under normal or foreseeable conditions of use, come into direct contact with human skin or the oral cavity in a prolonged or short-term manner. The December 2013 amendment introduced two sets of limits: one for articles used by the general public and a more stringent set of limits for toys and childcare items.

The draft guideline published by the ECHA in January 2017 also contains a non-exhaustive list of articles and subtypes that are considered to be within or outside the scope of the restriction. In addition, the guidelines present a ‘stepwise approach’ for stakeholders to use in identifying whether an article falls within the scope of the restrictions.

The guidelines state that PAHs may be found in:

• Mineral oils and coal-based extender/plasticizer oils, as a natural contaminant, that are used in the manufacture of rubber and plastic materials
• Carbon black (soot) that is intentionally added to elastomers to give certain characteristics such as color and flexibility
• Lacquers, varnishes or coatings

Stakeholders have until April 19, 2017, to make representation to the ECHA on the draft guidance. Following this, a final guideline will be published on the ECHA website to assist economic operators and enforcement authorities with compliance for PAH restrictions falling under Annex XVII of REACH.

SGS REACH Services
SGS will follow up and inform interested parties as developments on REACH regulation occur. Our expertise combined with consultancy services and experience in consumer product supply chains provides a central point of contact for global solutions. Learn more about SGS’s REACH Services (www.sgs.com/reach)

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full EU Seeks Comments for Draft Guideline on PAHs under REACH SafeGuardS. (www.sgs.com/en/news/2017/02/safeguards-02117-eu-seeks-comments-for-draft-guideline-on-pahs-under-reach)

Subscribe here, www.sgs.com/subscribesg, to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Hing Wo Tsang
Global Hardlines Information and Innovation Manager
Tel:(+852) 2774 7420
Email: cts.media@sgs.com
Website: www.sgs.com/cgnr

About SGS
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world.

1, Mons Calpe
Chitcombe Road
Broad Oak
Rye
East Sussex
TN31 6EU

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EU Publishes Draft Guidance and Seeks Comments on PAH Restrictions under REACH here

News-ID: 448313 • Views:

More Releases from SGS

SGS Summarizes Impact of EU Postponement of RED Cybersecurity Regulation Enforce …
SGS, the world's leading testing, inspection and certification company, has published SafeGuardS 095.23 to help stakeholders understand the impact of the decision to postpone the enforcement of the Radio Equipment Directive (RED) delegated act for cybersecurity until 2025. The European Commission (EC) originally planned to enforce the delegated act from August 2024. However, delays in the preparation of harmonized standards have meant the EC has now taken the decision to enforce
SGS Issues SafeGuardS for US CPSC Direct Final Rule for Bedside Sleepers
SGS, the world's leading testing, inspection and certification company, has published a SafeGuardS covering a recent direct final rule for bedside sleepers issued by the US Consumer Products Safety Commission (CPSC). Direct final rule 16 CFR 1222 was published on May 9, 2023, revising the safety standard for bedside sleepers. It incorporates the latest version of ASTM F2906-23 (Standard Consumer Safety Specification for Bedside Sleepers) with a modification. The modification involves
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit European Requirements for PPE
SGS Announces Complementary Webinar to Help Businesses Navigate Post-Brexit Euro …
SGS, the world's leading testing, inspection and certification company, has announced a webinar to help companies operating in European personal protective equipment (PPE) markets understand the implications of Brexit and the best route towards compliance. "Personal Protective Equipment: overview of EU and UK requirements" will be offered in two sessions on February 9, 2023, at 10.00 CET and 16.00 CET. It is aimed at operators throughout the PPE value chain, including
Patented pest management products now available direct from manufacturer
01-11-2023 | Energy & Environment
SGS
Patented pest management products now available direct from manufacturer
In 2023, IPS is taking a new pathway in the distribution of the company's flagship products. It is now possible to purchase the CLTab and SPTab solutions under the Insectrac brand name directly from IPS, the manufacturer. The company behind these unique products is International Pheromone Systems a customer-orientated company with 35 years of experience in developing, producing, and supplying high-quality insect pheromone and kairomone formulations and associated trapping systems to a

All 5 Releases


More Releases for PAH

Development: Pulmonary Arterial Hypertension (PAH) Market Growth Analysis
The global pulmonary arterial hypertension (pah) market is estimated to surpass $9,670.2 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027. The report provides all-inclusive analysis of global pulmonary arterial hypertension (pah) market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape. Research Methodology Research Dive offers its clients extensive research and analysis gleaned from wide
Pulmonary Arterial Hypertension (PAH) Market Research and Clinical Analysis 2020
Global Pulmonary Arterial Hypertension (PAH) Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Pulmonary Arterial Hypertension (PAH) Market research report identifies the competitive landscape of industries to understand the competition at International level.
Pulmonary Arterial Hypertension (PAH) Medicine Market (2020-2027) Report Offers …
The research study includes the latest updates about the COVID-19 impact on the Pulmonary Arterial Hypertension (PAH) Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy. The market research report on the global Pulmonary Arterial Hypertension (PAH) Medicine market provides an extensive and
Pulmonary Arterial Hypertension (PAH) - Market Outlook and Competitive Landscape …
Report Overview  The report provides a comprehensive view of disease events, types, severity, progression, symptoms, risk factors, pathogenesis and treatment guidelines at country level  Comprehensive insight on patient segmentation has been provided into the epidemiology of the Pulmonary Arterial Hypertension (PAH) and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China  Drug utilization and analysis on the current
Global Pulmonary Arterial Hypertension (PAH) Market| MarketResearchReports.biz
Latest industry research report on: Global Pulmonary Arterial Hypertension (PAH) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V
Pulmonary Arterial Hypertension (PAH) Market by Key Players 
Global Pulmonary Arterial Hypertension (PAH) Market: Snapshot Pulmonary arterial hypertension (PAH) is a very rare type of progressive disorder related to high blood pressure. However, the rate of incidence of this disorder is gradually gaining traction. Various sources, including WHO and CDC, suggest that the global prevalence of PAH is anticipated to be between 100,000 and 200,000, narrowing down to about 15-50 cases per million heads. There is no permanent cure